| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.973 | 0.002 | 0.973 | Topoisomerase II inhibitor | 0.952 0.002 DBMET00853 0.972 0.002 DBMET00367 0.972 0.002 DBMET01264 0.97 0.002 DBMET01265 | ||
| 0.937 | 0.004 | 0.963 | Transcription factor NF kappa B inhibitor | 0.963 0.002 DBMET00853 0.943 0.003 DBMET00367 0.943 0.003 DBMET01264 0.918 0.005 DBMET01265 | DBMET00853 | |
| 0.935 | 0.002 | 0.935 | DNA intercalator | 0.89 0.002 DBMET00853 0.932 0.002 DBMET00367 0.932 0.002 DBMET01264 0.928 0.002 DBMET01265 | ||
| 0.925 | 0.001 | 0.925 | Alkylator | 0.923 0.001 DBMET00853 0.921 0.001 DBMET00367 0.921 0.001 DBMET01264 0.906 0.001 DBMET01265 | ||
| 0.901 | 0 | 0.927 | Topoisomerase II beta inhibitor | 0.783 0.001 DBMET00853 0.927 0 DBMET00367 0.927 0 DBMET01264 0.864 0.001 DBMET01265 | DBMET01264 | |
| 0.853 | 0.003 | 0.853 | Antimitotic | 0.815 0.004 DBMET00853 0.853 0.003 DBMET00367 0.853 0.003 DBMET01264 0.849 0.003 DBMET01265 | ||
| 0.847 | 0.001 | 0.903 | DNA repair enzyme inhibitor | 0.903 0.001 DBMET00853 0.843 0.001 DBMET00367 0.843 0.001 DBMET01264 0.764 0.001 DBMET01265 | DBMET00853 | |
| 0.85 | 0.011 | 0.855 | Apoptosis agonist | 0.839 0.012 DBMET00853 0.855 0.01 DBMET00367 0.855 0.01 DBMET01264 0.845 0.011 DBMET01265 | DBMET01264 | |
| 0.838 | 0.003 | 0.85 | DNA damaging | 0.717 0.005 DBMET00853 0.85 0.003 DBMET00367 0.85 0.003 DBMET01264 0.813 0.004 DBMET01265 | DBMET01264 | |
| 0.836 | 0.002 | 0.836 | Topoisomerase II alpha inhibitor | 0.77 0.002 DBMET00853 0.832 0.002 DBMET00367 0.832 0.002 DBMET01264 0.814 0.002 DBMET01265 | ||
| 0.809 | 0.003 | 0.822 | Alpha tubulin antagonist | 0.509 0.004 DBMET00853 0.822 0.003 DBMET00367 0.822 0.003 DBMET01264 0.766 0.003 DBMET01265 | DBMET01264 | |
| 0.806 | 0.003 | 0.824 | Hypoxia-inducible factor 1 alpha inhibitor | 0.788 0.003 DBMET00853 0.824 0.003 DBMET00367 0.824 0.003 DBMET01264 0.774 0.003 DBMET01265 | DBMET01264 | |
| 0.793 | 0.012 | 0.822 | Caspase 9 stimulant | 0.62 0.033 DBMET00853 0.81 0.01 DBMET00367 0.81 0.01 DBMET01264 0.822 0.008 DBMET01265 | DBMET01265 | |
| 0.738 | 0.002 | 0.738 | Topoisomerase I inhibitor | 0.703 0.002 DBMET00853 0.736 0.002 DBMET00367 0.736 0.002 DBMET01264 0.733 0.002 DBMET01265 | ||
| 0.72 | 0.005 | 0.727 | Caspase 3 stimulant | 0.708 0.005 DBMET00853 0.727 0.005 DBMET00367 0.727 0.005 DBMET01264 0.711 0.005 DBMET01265 | DBMET01264 | |
| 0.587 | 0.005 | 0.609 | Tubulin antagonist | 0.416 0.011 DBMET00853 0.609 0.005 DBMET00367 0.609 0.005 DBMET01264 0.578 0.005 DBMET01265 | DBMET01264 | |
| 0.534 | 0.006 | 0.619 | Hepatoprotectant | 0.619 0.004 DBMET00853 0.544 0.005 DBMET00367 0.544 0.005 DBMET01264 0.515 0.006 DBMET01265 | DBMET00853 | |
| 0.518 | 0.018 | 0.589 | Antioxidant | 0.589 0.012 DBMET00853 0.556 0.015 DBMET00367 0.556 0.015 DBMET01264 0.487 0.021 DBMET01265 | DBMET00853 | |
| 0.501 | 0.004 | 0.527 | Beta tubulin antagonist | 0.248 0.005 DBMET00853 0.527 0.004 DBMET00367 0.527 0.004 DBMET01264 0.499 0.004 DBMET01265 | DBMET01264 | |
| 0.503 | 0.032 | 0.519 | Immunosuppressant | 0.519 0.028 DBMET00853 0.501 0.033 DBMET00367 0.501 0.033 DBMET01264 0.5 0.033 DBMET01265 | DBMET00853 | |
| 0.46 | 0.053 | 0.612 | Antibacterial | 0.612 0.017 DBMET00853 0.478 0.047 DBMET00367 0.478 0.047 DBMET01264 0.514 0.037 DBMET01265 | DBMET00853 | |
| 0.423 | 0.024 | 0.554 | Hypoglycemic | 0.554 0.011 DBMET00853 0.433 0.023 DBMET00367 0.433 0.023 DBMET01264 0.417 0.025 DBMET01265 | DBMET00853 | |
| 0.42 | 0.023 | 0.47 | Nitric oxide antagonist | 0.47 0.018 DBMET00853 0.433 0.022 DBMET00367 0.433 0.022 DBMET01264 0.392 0.026 DBMET01265 | DBMET00853 | |
| 0.403 | 0.009 | 0.497 | Amylase inhibitor | 0.497 0.006 DBMET00853 0.443 0.007 DBMET00367 0.443 0.007 DBMET01264 0.338 0.014 DBMET01265 | DBMET00853 | |
| 0.39 | 0.031 | 0.483 | Free radical scavenger | 0.483 0.018 DBMET00853 0.439 0.023 DBMET00367 0.439 0.023 DBMET01264 0.348 0.039 DBMET01265 | DBMET00853 | |
| 0.407 | 0.071 | 0.457 | 15-Lipoxygenase inhibitor | 0.457 0.052 DBMET00367 0.457 0.052 DBMET01264 0.435 0.06 DBMET01265 | DBMET01264 | |
| 0.34 | 0.022 | 0.34 | P-glycoprotein inhibitor | 0.287 0.031 DBMET00853 0.34 0.022 DBMET00367 0.34 0.022 DBMET01264 0.322 0.025 DBMET01265 | ||
| 0.316 | 0.02 | 0.352 | Peptidyltransferase inhibitor | 0.352 0.012 DBMET00853 0.318 0.019 DBMET00367 0.318 0.019 DBMET01264 0.311 0.021 DBMET01265 | DBMET00853 | |
| 0.33 | 0.039 | 0.47 | Angiogenesis stimulant | 0.47 0.014 DBMET00853 0.336 0.037 DBMET00367 0.336 0.037 DBMET01264 0.299 0.05 DBMET01265 | DBMET00853 | |
| 0.297 | 0.022 | 0.326 | Melanin inhibitor | 0.248 0.029 DBMET00853 0.326 0.019 DBMET00367 0.326 0.019 DBMET01264 0.254 0.028 DBMET01265 | DBMET01264 | |
| 0.321 | 0.046 | 0.376 | Platelet antagonist | 0.376 0.032 DBMET00853 0.317 0.047 DBMET00367 0.317 0.047 DBMET01264 0.291 0.056 DBMET01265 | DBMET00853 | |
| 0.408 | 0.135 | 0.592 | Antiinflammatory | 0.592 0.056 DBMET00853 0.434 0.119 DBMET00367 0.434 0.119 DBMET01264 0.407 0.135 DBMET01265 | DBMET00853 | |
| 0.276 | 0.004 | 0.281 | Microtubule formation inhibitor | 0.276 0.004 DBMET00853 0.277 0.004 DBMET00367 0.277 0.004 DBMET01264 0.281 0.003 DBMET01265 | DBMET01265 | |
| 0.312 | 0.045 | 0.344 | Pyruvate kinase inhibitor | 0.344 0.036 DBMET00367 0.344 0.036 DBMET01264 0.174 0.097 DBMET01265 | DBMET01264 | |
| 0.287 | 0.053 | 0.305 | Vasodilator | 0.304 0.047 DBMET00853 0.305 0.046 DBMET00367 0.305 0.046 DBMET01264 0.238 0.076 DBMET01265 | DBMET01264 | |
| 0.303 | 0.084 | 0.372 | Apoptosis antagonist | 0.372 0.047 DBMET00853 0.319 0.073 DBMET00367 0.319 0.073 DBMET01264 0.273 0.105 DBMET01265 | DBMET00853 | |
| 0.196 | 0.015 | 0.198 | Antineoplastic alkaloid | 0.132 0.033 DBMET00853 0.198 0.014 DBMET00367 0.198 0.014 DBMET01264 0.189 0.017 DBMET01265 | DBMET01264 | |
| 0.249 | 0.067 | 0.321 | DNA synthesis inhibitor | 0.321 0.037 DBMET00853 0.227 0.086 DBMET00367 0.227 0.086 DBMET01264 0.24 0.073 DBMET01265 | DBMET00853 | |
| 0.207 | 0.037 | 0.211 | Interleukin 6 antagonist | 0.196 0.043 DBMET00853 0.211 0.035 DBMET00367 0.211 0.035 DBMET01264 0.194 0.044 DBMET01265 | DBMET01264 | |
| 0.179 | 0.025 | 0.215 | Antineoplastic antibiotic | 0.215 0.019 DBMET00853 0.178 0.025 DBMET00367 0.178 0.025 DBMET01264 0.19 0.023 DBMET01265 | DBMET00853 | |
| 0.136 | 0.011 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.13 0.014 DBMET00853 0.138 0.011 DBMET00367 0.138 0.011 DBMET01264 0.126 0.016 DBMET01265 | DBMET01264 | |
| 0.133 | 0.02 | 0.236 | Selectin antagonist | 0.236 0.009 DBMET00853 0.142 0.019 DBMET00367 0.142 0.019 DBMET01264 0.09 0.032 DBMET01265 | DBMET00853 | |
| 0.173 | 0.086 | 0.28 | Platelet adhesion inhibitor | 0.28 0.04 DBMET00853 0.188 0.077 DBMET00367 0.188 0.077 DBMET01264 0.142 0.115 DBMET01265 | DBMET00853 | |
| 0.152 | 0.067 | 0.174 | Lipid peroxidase inhibitor | 0.166 0.058 DBMET00853 0.174 0.053 DBMET00367 0.174 0.053 DBMET01264 0.141 0.074 DBMET01265 | DBMET01264 | |
| 0.177 | 0.102 | 0.194 | Neurotrophic factor enhancer | 0.194 0.083 DBMET00367 0.194 0.083 DBMET01264 0.147 0.142 DBMET01265 | DBMET01264 | |
| 0.192 | 0.127 | 0.246 | Spasmolytic | 0.246 0.093 DBMET00853 0.212 0.11 DBMET00367 0.212 0.11 DBMET01264 0.172 0.144 DBMET01265 | DBMET00853 | |
| 0.095 | 0.034 | 0.102 | Keratolytic | 0.102 0.029 DBMET00367 0.102 0.029 DBMET01264 0.083 0.045 DBMET01265 | DBMET01264 | |
| 0.081 | 0.021 | 0.083 | Nitric oxide donor | 0.083 0.02 DBMET00853 0.081 0.021 DBMET00367 0.081 0.021 DBMET01264 0.078 0.024 DBMET01265 | DBMET00853 | |
| 0.074 | 0.018 | 0.076 | Lipocortins synthesis agonist | 0.075 0.017 DBMET00853 0.074 0.018 DBMET00367 0.074 0.018 DBMET01264 0.076 0.017 DBMET01265 | DBMET01265 | |
| 0.074 | 0.022 | 0.086 | Protein 50S ribosomal subunit inhibitor | 0.086 0.017 DBMET00853 0.073 0.023 DBMET00367 0.073 0.023 DBMET01264 0.074 0.022 DBMET01265 | DBMET00853 | |
| 0.108 | 0.06 | 0.184 | Expectorant | 0.184 0.024 DBMET00853 0.119 0.051 DBMET00367 0.119 0.051 DBMET01264 | DBMET00853 | |
| 0.053 | 0.011 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.007 DBMET00853 0.053 0.012 DBMET00367 0.053 0.012 DBMET01264 0.053 0.012 DBMET01265 | DBMET00853 | |
| 0.16 | 0.125 | 0.175 | Histone acetyltransferase inhibitor | 0.175 0.107 DBMET00367 0.175 0.107 DBMET01264 | DBMET01264 | |
| 0.059 | 0.025 | 0.078 | Glucose-6-phosphate translocase inhibitor | 0.078 0.012 DBMET00853 0.064 0.02 DBMET00367 0.064 0.02 DBMET01264 0.051 0.036 DBMET01265 | DBMET00853 | |
| 0.084 | 0.063 | 0.088 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET00367 0.086 0.061 DBMET01264 0.088 0.058 DBMET01265 | DBMET01265 | |
| 0.047 | 0.032 | 0.052 | Microtubule stabilization | 0.052 0.025 DBMET00853 0.047 0.032 DBMET00367 0.047 0.032 DBMET01264 0.048 0.03 DBMET01265 | DBMET00853 | |
| 0.198 | 0.184 | 0.295 | Vasodilator, coronary | 0.295 0.091 DBMET00853 0.213 0.17 DBMET00367 0.213 0.17 DBMET01264 0.226 0.158 DBMET01265 | DBMET00853 | |
| 0.08 | 0.069 | 0.087 | Transcription factor NF kappa B stimulant | 0.087 0.056 DBMET00853 0.082 0.066 DBMET00367 0.082 0.066 DBMET01264 | DBMET00853 | |
| 0.096 | 0.088 | 0.098 | CDC-like kinase 3 inhibitor | 0.098 0.084 DBMET00367 0.098 0.084 DBMET01264 | DBMET01264 | |
| 0.023 | 0.018 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET00853 0.023 0.018 DBMET00367 0.023 0.018 DBMET01264 0.022 0.02 DBMET01265 | DBMET00853 | |
| 0.187 | 0.185 | 0.212 | Angiogenesis inhibitor | 0.212 0.156 DBMET00853 0.194 0.176 DBMET00367 0.194 0.176 DBMET01264 | DBMET00853 | |
| 0.024 | 0.022 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | 0.05 0.006 DBMET00853 | DBMET00853 | |
| 0.081 | 0.079 | 0.087 | Protein kinase C mu inhibitor | 0.087 0.071 DBMET00367 0.087 0.071 DBMET01264 | DBMET01264 | |
| 0.019 | 0.019 | 0.02 | Corticosteroid-like | 0.02 0.016 DBMET00853 0.019 0.018 DBMET01265 | DBMET00853 | |
| 0.021 | 0.036 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET00853 | DBMET00853 | |
| 0.113 | 0.131 | 0.136 | NOS3 expression enhancer | 0.136 0.089 DBMET00853 0.128 0.101 DBMET00367 0.128 0.101 DBMET01264 | DBMET00853 | |
| 0.224 | 0.243 | 0.512 | Cyclophilin D inhibitor | 0.512 0.047 DBMET00853 0.238 0.226 DBMET00367 0.238 0.226 DBMET01264 | DBMET00853 | |
| 0.045 | 0.076 | 0.056 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 DBMET00367 0.056 0.052 DBMET01264 | DBMET01264 | |
| 0.1 | 0.197 | 0.124 | Interferon gamma antagonist | 0.124 0.123 DBMET00853 | DBMET00853 | |
| 0.064 | 0.169 | 0.084 | T cell inhibitor | 0.084 0.051 DBMET01265 | DBMET01265 | |
| 0.093 | 0.234 | 0.273 | Immunostimulant | 0.273 0.087 DBMET00853 | DBMET00853 | |
| 0.059 | 0.228 | 0.123 | Cyclooxygenase 3 inhibitor | 0.123 0.074 DBMET00853 | DBMET00853 | |
| 0.13 | 0.358 | 0.22 | Interleukin 2 agonist | 0.22 0.157 DBMET00853 | DBMET00853 | |
| 0.101 | 0.345 | 0.243 | Antithrombotic | 0.243 0.132 DBMET00853 | DBMET00853 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |